Issue 28, 2013

A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)

Abstract

A stable Re complex containing an imidazopyridine ligand with a high affinity for TSPO has been synthesized as a model for new 99mTc or 188/186Re-based radiopharmaceuticals to be used in SPECT diagnosis or in therapy, respectively. The new complex fac-[ReBr(CO)3(TZ6)], structurally characterized, showed high affinity (nanomolar concentration) for the target protein.

Graphical abstract: A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)

Supplementary files

Article information

Article type
Communication
Submitted
02 May 2013
Accepted
21 May 2013
First published
21 May 2013

Dalton Trans., 2013,42, 10112-10115

A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO)

S. Piccinonna, N. Margiotta, N. Denora, R. M. Iacobazzi, C. Pacifico, G. Trapani and G. Natile, Dalton Trans., 2013, 42, 10112 DOI: 10.1039/C3DT51152A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements